INTRODUCTION AND OBJECTIVES: The Life-Space Assessment can be used to measure a patient's level of mobility. This study evaluated the relationship between life-space mobility and frequency of hospitalization in the previous year and other clinical markers of health among adults with cystic fibrosis (CF). METHODS: The Life-Space Assessment was administered to ambulatory adults with CF in clinic or by telephone. Life-space mobility was correlated with the most recent forced expiratory volume in one second as a percent of the predicted value (FEV(1) % predicted), body mass index (BMI) and number of hospitalizations in the previous year. RESULTS: Forty-eight subjects completed the Life-Space Assessment. Subjects had a life-space score of 88 ± 26, FEV(1) % predicted of 66% ± 26% and BMI of 22.5 ± 3.3. There was a statistically significant negative linear correlation between the number of times a subject was hospitalized in the previous year and life-space mobility (P = 0.001, R(2) = 0.20). This association was independent of FEV(1) % predicted and BMI. CONCLUSION: The life-space mobility score is associated with frequency of hospitalization in adults with CF. A prospective study should be undertaken to assess the ability of the Life-Space Assessment to predict hospitalization and other outcomes in adults with CF.
INTRODUCTION AND OBJECTIVES: The Life-Space Assessment can be used to measure a patient's level of mobility. This study evaluated the relationship between life-space mobility and frequency of hospitalization in the previous year and other clinical markers of health among adults with cystic fibrosis (CF). METHODS: The Life-Space Assessment was administered to ambulatory adults with CF in clinic or by telephone. Life-space mobility was correlated with the most recent forced expiratory volume in one second as a percent of the predicted value (FEV(1) % predicted), body mass index (BMI) and number of hospitalizations in the previous year. RESULTS: Forty-eight subjects completed the Life-Space Assessment. Subjects had a life-space score of 88 ± 26, FEV(1) % predicted of 66% ± 26% and BMI of 22.5 ± 3.3. There was a statistically significant negative linear correlation between the number of times a subject was hospitalized in the previous year and life-space mobility (P = 0.001, R(2) = 0.20). This association was independent of FEV(1) % predicted and BMI. CONCLUSION: The life-space mobility score is associated with frequency of hospitalization in adults with CF. A prospective study should be undertaken to assess the ability of the Life-Space Assessment to predict hospitalization and other outcomes in adults with CF.
Authors: B S Gilson; J S Gilson; M Bergner; R A Bobbit; S Kressel; W E Pollard; M Vesselago Journal: Am J Public Health Date: 1975-12 Impact factor: 9.308
Authors: Kerry M Sheets; Allyson M Kats; Lisa Langsetmo; Dawn Mackey; Howard A Fink; Susan J Diem; Wei Duan-Porter; Peggy M Cawthon; John T Schousboe; Kristine E Ensrud Journal: J Am Geriatr Soc Date: 2021-05-07 Impact factor: 7.538
Authors: Anand S Iyer; James M Wells; Surya P Bhatt; deNay P Kirkpatrick; Patricia Sawyer; Cynthia J Brown; Richard M Allman; Marie A Bakitas; Mark T Dransfield Journal: Int J Chron Obstruct Pulmon Dis Date: 2018-09-04